IP Library Granted Patent US 9,606,032
Granted Patent B2
US 9,606,032 · App. 15/178,485 · Granted Mar 28, 2017

Preparation of samples for analysis and sampling device therefor

Inventors: Andrew Gooley (Ringwood, AU); Hans-Jurgen Wirth (Ringwood, AU); Emily Frances Hilder (Sandy Bay, AU); Wei Boon Hon (Sandy Bay, AU)
Assignee: Trajan Scientific Australia Pty Ltd
G01N1/405B01L3/0275G01N1/10B01L2200/0631
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,606,032
App. No.
15/178,485
Granted
Mar 28, 2017
Kind
B2
Abstract

A sampling device comprising a body that defines a fluid flow path from an inlet opening, wherein the flow path includes a bed of a porous polymer monolith selected to adsorb bioparticles from a matrix drawn or dispensed through the inlet opening and the bed.

Claims (11)

1. A method of preparing for analysis a matrix containing bioparticles, comprising:

drawing or dispensing a volume of the matrix along a flow path defined by a sampling body through a bed of porous polymer monolith in the flow path, which bed is of sufficient length along the flow path whereby the bed adsorbs the bioparticles and a sub-volume of the matrix substantially free of the bioparticles remains adjacent to the bioparticles in the sampling body; and

recovering matrix from the sub-volume for analysis.

2. A method according to claim 1 wherein said body is a tubular body and the bed is a plug of the porous polymer monolith that fills a cross-section of the flow path.

3. A method according to claim 2 wherein the porous polymer monolith is a result of polymerisation of two or more monomers in the presence of two or more porogens.

4. A method according to claim 1 including forming the bed in situ by initiation of a polymerisation mixture within said body.

5. A method according to claim 4 wherein said initiation is by ultraviolet radiation.

6. A method according to claim 1 wherein the porous polymer monolith is a result of polymerisation of two or more monomers in the presence of two or more porogens.

7. A method according to claim 6 wherein the monomers are methacrylates and the porogens include an alcohol and an alkane.

8. A method according to claim 1 wherein the porous monomer monolith is selected to adsorb at least red blood cells from whole or buffered blood.

9. A method according to claim 8 wherein the porous polymer monolith is selected to additionally adsorb white blood cells and platelets from the whole or buffered blood whereby to obtain a cell-free plasma or plasma-like fraction.

Assignments (1)
SECURITY INTEREST Recorded Aug 29, 2025
From: TRAJAN SCIENTIFIC AMERICAS INC.; CHROMATOGRAPHY RESEARCH SUPPLIES, LLC
To: TASOVAC PTY LIMITED ABN 51 108 013 467
Reel/Frame 072758/0663 →
Priority Claims (1)
AU 2014900265 · Jan 29, 2014 · national
Continuity (2)
Division 14608061 · Jan 28, 2015
Related Publication 20160290902A1 · Oct 6, 2016